Exam 39: Osteoporosis Treatment

A 60-year-old woman is in the clinic for an annual well-woman examination.She has been taking alendronate (Fosamax)10 mg daily for 4 years.Her last bone density test yielded a T-score of 2.0.Her urine NTx level today is 22.She walks daily.Her fracture risk is low.The primary care NP should recommend that she:

A 70-year-old patient who has a high fracture risk has been taking alendronate (Fosamax)and calcium for 6 months.The primary care NP orders a urine NTx level,which is 42.The NP should discontinue the alendronate and prescribe:

A 50-year-old woman with osteopenia will begin taking raloxifene (Evista).When counseling this patient about this drug regimen,the primary care NP should tell her to:

A 55-year-old woman who experienced menopause at age 50 years undergoes central dual-energy x-ray absorptiometry and has a T-score greater than 2.5.The patient weighs 130 lb and has a body mass index of 22.She sits at a computer all day at work.The primary care nurse practitioner (NP)caring for this patient should:

A patient who has several risk factors for osteoporosis has a bone density test that indicates osteopenia.The primary care NP plans to prescribe a bisphosphonate.Before initiating treatment,the NP should:

A 60-year-old woman has a central dual-energy x-ray absorptiometry with a T-score of 1.9.A health history reveals no risk factors for osteoporosis.The primary care NP should:

A 50-year-old white woman who is experiencing menopause asks the primary care NP what she can do to prevent osteoporosis.She has a negative family history and no risk factors.The NP should counsel her to:

A 60-year-old female patient has begun taking a daily bisphosphonate to prevent osteoporosis and complains of gastrointestinal (GI)upset and dyspepsia.The primary care NP's initial response should be to: